Literature DB >> 6095858

Species variation in the ouabain sensitivity of cardiac Na+/K+-ATPase. A possible role for membrane lipids.

M Y Abeywardena, E J McMurchie, G R Russell, J S Charnock.   

Abstract

The role of membrane lipid composition on the modulation of ouabain sensitivity of cardiac Na+/K+-ATPase has been studied in vitro using several animal species. The animals can be grouped as ouabain-sensitive and ouabain-insensitive species. Ouabain-sensitive species (I50; 0.5-2.2 microM) include sheep, marmoset, pig and the guinea pig, whilst rat and mouse form the ouabain-insensitive group (I50; 100-105 microM). Although no species variation in the distribution of major phospholipid classes was observed, significant differences were apparent in the proportions of certain saturated and unsaturated phospholipid fatty acids. Thus, there was a marked increase in the relative proportion of docosahexaenoic (22:6, omega-3) acid in the Na+/K+-ATPase preparations from the rat and mouse compared to ouabain-sensitive species. Despite these differences, all animals had similar proportions of total saturated (sigma SAT) and total unsaturated (sigma Unsat) fatty acids. On the other hand, a good correlation between the unsaturation index of membrane lipids and I50 value for ouabain was observed. It is proposed that acyl chain characteristics (unsaturation and/or chain length) rather than the head group of the phospholipid molecule play a major role in the modulation of Na+/K+-ATPase to inhibition by ouabain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095858     DOI: 10.1016/0006-2952(84)90152-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Significance of binding to Na,K-ATPase in the tissue distribution of ouabain in guinea pigs.

Authors:  H Harashima; M Mamiya; M Yamazaki; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

Review 2.  The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase.

Authors:  Jerry B Lingrel
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

3.  Phospholipid composition of cardiac (Na+ + K+)-ATPases from various species.

Authors:  T Matsuda; H Iwata
Journal:  Experientia       Date:  1986-04-15

Review 4.  Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death.

Authors:  P L McLennan; M Y Abeywardena
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

5.  Different sensitivity of ATP + Mg + Na (I) and Pi + Mg (II) dependent types of ouabain binding to phospholipase A2.

Authors:  P Svoboda; E Amler; J Teisinger
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

6.  AKT activation promotes PTEN hamartoma tumor syndrome-associated cataract development.

Authors:  Caterina Sellitto; Leping Li; Junyuan Gao; Michael L Robinson; Richard Z Lin; Richard T Mathias; Thomas W White
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

Review 7.  Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain.

Authors:  Luiz H A Cavalcante-Silva; Éssia de Almeida Lima; Deyse C M Carvalho; José M de Sales-Neto; Anne K de Abreu Alves; José G F M Galvão; Juliane S de França da Silva; Sandra Rodrigues-Mascarenhas
Journal:  Front Physiol       Date:  2017-11-10       Impact factor: 4.566

8.  Inhibitory efficacy of bufadienolides on Na+,K+-pump activity versus cell proliferation.

Authors:  Yinfang Xu; Xuan Liu; Silvia Schwarz; Lihong Hu; Dean Guo; Quanbao Gu; Wolfgang Schwarz
Journal:  Biochem Biophys Rep       Date:  2016-03-31

9.  Rise in DPA Following SDA-Rich Dietary Echium Oil Less Effective in Affording Anti-Arrhythmic Actions Compared to High DHA Levels Achieved with Fish Oil in Sprague-Dawley Rats.

Authors:  Mahinda Y Abeywardena; Michael Adams; Julie Dallimore; Soressa M Kitessa
Journal:  Nutrients       Date:  2016-01-04       Impact factor: 5.717

10.  Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart.

Authors:  Yu Jin Chung; Kyung Chan Park; Sergiy Tokar; Thomas R Eykyn; William Fuller; Davor Pavlovic; Pawel Swietach; Michael J Shattock
Journal:  Cardiovasc Res       Date:  2021-12-17       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.